Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Introduction: Complete pathologic response (CPR) is an acceptable surrogate for survival in clinical trials but it occurs infrequently in patients with NSCLC receiving neoadjuvant chemotherapy (NCT). Therefore, we studied the impact of major pathologic response (MPR) for predicting survival of patie...

Full description

Bibliographic Details
Main Authors: Apar Pataer, MD, PhD, Annikka Weissferdt, MD, Arlene M. Correa, PhD, Ara A. Vaporciyan, MD, Boris Sepesi, MD, John V. Heymach, MD, Sabina Berezowska, MD, Tina Cascone, MD, Stephen G. Swisher, MD
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:JTO Clinical and Research Reports
Subjects:
Lung cancer
Neoadjuvant chemotherapy
Major pathologic response
Non–small cell lung cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322001448

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322001448

Similar Items